The Role of Epigenetic Changes in The Development of Diabetes Mellitus

Wardhana Wardhana, Djoko Wahono Soeatmadji


Diabetes mellitus (DM) is one of the most abundant diseases in the 21st century and believed as result of interaction between genes and environment exposure. There is a hypotesis of epigenetic mechanisms, using molecular basis to explain about the mechanism of DM. Because of the enviromental exposure including nutrition status and hyperglycemia state, the risk of DM has started since pre-conception, last until adulthood and will be inhireted trans-generational . Mainly, there are 3 epigenetic mechanisms that have role in DM. Epigenetic mechanisms are also have role in the metabolic memory that the DM complications may still developed although the blood glucose level is already normal. The restriction of calory intake may help delaying the development and onset of degerative diseases including DM by stabilizing genome through epigenetic mechanisms.


Diabetes; epigenetic mechanisms; metabolic memory


Gouti A, Dekaken A. Epigenetic pathways in type 2 diabetes and its complications. Med Pub J. 2013;1(11):1-5.

Zheng J, Xiao X, Zhang Q, Yu M. DNA methylation: the pivotal interaction between early-life nutrition and glucose metabolism in later life. Br J Nutr. 2014;112:1850-7.

Moosavi A, Ardekani AM. Role of epigenetics in biology and human diseases. Iran Biomed. 2016;20(5):246-58.

Day J, Savani S, Krepley BD, et al. Influence of paternal preconception exposures on their offspring: though epigenetics to phenotype. Am J Stem Cells. 2016;5(1):11-8.

Hajj NE, Schneider E, Lehnen H, Haaf T. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauterine environment. Reproduction. 2014;148:R111-R120.

Dijk SV, Molloy PL, Varinli H, et al. Epigenetics and human obesity. Int J Obes.2015;39:85-97.

Rissman EF, Adli M. Transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinol. 2014;155:2770-80.

Ding GL, Huang HF. Role for Tet in hyperglycemia-induced demethylation:a novel mechanism of diabetic metabolic memory. Diabetes. 2014;63:2906-8.

Grayson SE, de Leon FAP, Muscoplat CC. Epigenetics: understanding how our choices lead to our diseases. J Clin Case Rep. 2014;4(11):1-6.

Rehan MK. Epigenetics and diabetes mellitus. The Egypt J Intern Med.2016;28:39-51.

Smith CJ, Ryckman KK. Epigenetic and developmental influences on the risk of obesity, diabets, and metabolic syndrome. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2015;8:295-302.

Sterns JD, Smith CB, Steele JR, et al. Epigenetics and type II diabetes mellitus:underlying mechanisms of prenatal predisposition. Frontiers Cell Develop Biol. 2014;2:article 15.

Martinez JA, Milagro FI, Claycombe KJ, Schalinske KL. Epigenetics in adipose tissue,obesity,weight loss, and diabetes. Adv Nutr. 2014;5:71-81.

Fleisch AF, Wright RO, Baccarelli AA. Environmental epigenetics: a role in endocrine disease? J Mol Endocrinol. 2012;49:R61-R67.

Li En, Zhang Y. DNA methylation in mammals. Cold Spring Harb Perspect Biol. 2014;6:a019133.

Intine RV, Sarras Jr MP. Metabolic memory and chronic diabetes complications:potential role for epigenetic mechanisms. Curr Diab Rep. 2012;12(5):551-9.

Dayeh T, Volkov P, Salo S, et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabeteic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLOS Genetic. 2014;10(3):e1004160.

Choi SW, Friso S. Epigenetics: a new bridge between nutrition and health. Adv Nutr. 2010;1:8-16.

Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693-705.

Gurusamy N, Sukumaran V, Alhazzani A, et al. Complications of diabetes: an unsolicited epigenetic memory. Diabesity. 2015;1:3-6.

Miao F, Wu X, Zhang L, et al. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Niological Chemist. 2007;282(10):13854-63.

Handy DE, Castro R, Loscalzo J. Epigenetic modifications basic mechanisms and role in cardiovascular disease. Circulation. 2011;123:2145-56.

Sato F, Tsuchiya S, Melzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J. 2011;278:1598-609.

Muhonen P, Holthofer H. Epigenetic and microRNA-mediated regulation in diabetes. Nephrol Dial Transplant. 2009;24:1088-96.

Joglekar MV, Parekh VS, Hardikar AA. Islet-specific microRNAs in pancreas development, regeneration and diabetes. Indian J Experiment Biol. 2011;49:401-8.

Togliatto G, Dentelli P, Vrizzi MF. Skewed epigenetics: an alternative therapeutic option gor diabetes complications. J Diab Res. 2015;article ID 373708:7 pages.

Paneni F, Volpe M, Luscher TF, et al. SIRT1, p66shc, and Set7/9 in vascular hyperglycemic memory. Diabetes. 2013;62:1800-7.

Bender SB, McGraw AP, Jaffe IZ, Sowers JR. Mineralocorticoid receptor-mediated vascular insulin resistance. An early contributor to diabetes-related vascular disease? Diabetes. 2013;63:313-9.

Jia L, Xing J, Ding Y, et al. Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κβ signaling pathway. Plos ONE. 2013;8(10):e78284.

Full Text: PDF


  • There are currently no refbacks.

Copyright (c) 2019 Acta Medica Indonesiana